The Use of Rechargeable Spinal Cord Stimulators for the Treatment of Neuropathic Pain

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2023

Primary Completion Date

April 17, 2023

Study Completion Date

June 30, 2023

Conditions
Neuropathic Pain
Interventions
OTHER

F-SUS Questionnaire

"This F-SUS questionnaire uses a Likert scale including 5 possible responses ranging from I do not agree at all to I completely agree (Celenza A 2011, Croasmun JT 2011). The F-SUS is a short questionnaire with 10 questions (Brooke J 2013). In its original version half of the questions express strong agreement and the other half disagreement. Thus, all the even-numbered items (2, 4, 6, 8, 10) allow the participant to express a very negative opinion (disagreement). On the other hand, the odd-numbered items allow the participant to express a very positive opinion (strong agreement)."

OTHER

Interview (only for dissatisfied patients)

"Patients that are dissatisfied with the recharge procedure (Score F-SUS \< 70/100) will be invited to a so-called complementary information interview (an interview after the questionnaire has been completed).~The corpus (the study group that will be interviewed) will naturally be diverse men/women, patients who were improved or not by stimulation, implanted with a rechargeable stimulator directly/replacing a stimulator, different brands of stimulator… The patient must agree to the interview and the way it will be performed (signature of consent form). The interview may be face-to -face at the site or by remote videoconference depending on the wishes and availability of the patient. There is no payment for these interviews but travelling or videoconference expenses are reimbursed All interviews will be audio- taped for further qualitative analysis."

Trial Locations (1)

44000

Clinique Brétéché, Nantes

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Elsan

OTHER

NCT05373654 - The Use of Rechargeable Spinal Cord Stimulators for the Treatment of Neuropathic Pain | Biotech Hunter | Biotech Hunter